Back to Search Start Over

Agilent Technologies to buy North American CDMO, Biovectra for $925 million

Source :
PharmaBiz. July 24, 2024
Publication Year :
2024

Abstract

Agilent Technologies Inc. announced it has signed a definitive agreement to acquire Biovectra, a leading specialized contract development and manufacturing organization (CDMO), for $925 million. Based in Canada, Biovectra produces [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
PharmaBiz
Publication Type :
Periodical
Accession number :
edsgcl.802410180